Zobrazeno 1 - 10
of 89
pro vyhledávání: '"D, Medhurst A"'
Autor:
Daniel G. Shore, Andrew D. Medhurst, Zachary Kevin Sweeney, Xingrong Liu, Andrew W. Gill, Edward G. McIver, John Moffat, Jason Drummond, Alan Beresford, Bryan K. Chan, Tracy Kleinheinz, Haitao Zhu, Huifen Chen, Anthony A. Estrada
Publikováno v:
Bioorganicmedicinal chemistry letters. 29(4)
The discovery of disease-modifying therapies for Parkinson’s Disease (PD) represents a critical need in neurodegenerative medicine. Genetic mutations in LRRK2 are risk factors for the development of PD, and some of these mutations have been linked
Autor:
John Atherall, Bryan K. Chan, Tracy Kleinheinz, Daniel G. Shore, Andrew D. Medhurst, Huifen Chen, Haitao Zhu, Anthony A. Estrada, Sara L. Dominguez, Kimberly Scearce-Levie, Jason Drummond, Alan Beresford, Kevin M. Nash, Zejuan Sheng, Mark Stuart Chambers, Zachary Kevin Sweeney, Andrew Gill, Claire E. Le Pichon, Shuo Zhang, Charles Baker-Glenn, John Moffat, Hervé Van de Poël, Daniel J. Burdick, Xingrong Liu
Publikováno v:
ACS Medicinal Chemistry Letters. 4:85-90
The modulation of LRRK2 kinase activity by a selective small molecule inhibitor has been proposed as a potentially viable treatment for Parkinson's disease. By using aminopyrazoles as aniline bioisosteres, we discovered a novel series of LRRK2 inhibi
Autor:
Gordon K. Wilcock, Margaret M. Esiri, Mitchell K.P. Lai, Andrew D. Medhurst, Jasinda H. Lee, Peter T.-H. Wong, Yuan Sheng, Christopher Chen
Publikováno v:
Journal of the Neurological Sciences. 315:110-114
Aim: Histamine H3 receptor antagonists have been proposed as a novel therapeutic approach for the symptomatic treatment of Alzheimer's disease (AD). However, it is unclear whether there is a neurochemical basis for extending their potential use in va
Autor:
Andrew D. Medhurst, Maria Grazia Giovannini, Laura Della Corte, Patrizia Giannoni, Chiara Ballini, Patrizio Blandina, Maria Beatrice Passani
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 332:164-172
After oral administration, the nonimidazole histamine H3 receptor antagonist, 6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-N-methyl-3-pyridinecarboxamide hydrochloride (GSK189254), increased histamine release from the tuberomammillar
Autor:
Andrew D. Medhurst, Ciaran M. Regan, Claire Barry, Darren Scully, Alison Prendergast, Andrew G. Foley, Neil Upton
Publikováno v:
Neuropsychopharmacology. 34:2585-2600
To further understand the procognitive actions of GSK189254, a histamine H(3) receptor antagonist, we determined its influence on the modulation of hippocampal neural cell adhesion molecule (NCAM) polysialylation (PSA) state, a necessary neuroplastic
Autor:
Lauren Broom, David T. Dexter, Lilia Marinova-Mutafchieva, Andrew D. Medhurst, John B. Davis, Mona Sadeghian
Publikováno v:
Journal of Neurochemistry. 110:966-975
Cellular interactions between activated microglia and degenerating neurons in in vivo models of Parkinson's disease are not well defined. This time course study assesses the dynamics of morphological and immunophenotypic properties of activated micro
Autor:
Andrew D. Medhurst, Patricia Franco, Neil Upton, RX Guo, Jenny C. Roberts, Mei Zhang, JQ Feng, Régis Parmentier, S. H. Brown, Christelle Anaclet, Jean-Pierre Sastre, Jian-Sheng Lin, Colette Buda, G. Guidon
Publikováno v:
British Journal of Pharmacology. 157:104-117
Background and purpose: Histamine H3 receptor antagonists are currently being evaluated in clinical trials for a number of central nervous system disorders including narcolepsy. These agents can increase wakefulness (W) in cats and rodents following
Autor:
Andrew D. Medhurst, Jennifer C. Roberts, John B. Davis, David Virley, Marion J. Perren, Sarah Friel, Shilina Roman, Jill C. Richardson, Alex J. Harper
Publikováno v:
Experimental Neurology. 216:459-470
Chronic inflammation is known to occur in the brains of Alzheimer's Disease (AD) patients, including the presence of activated microglia close to amyloid plaques. We utilised real time autoradiography and immunohistochemistry to investigate microglia
Autor:
S. H. Brown, Jenny C. Roberts, J. Lee, Shilina Roman, Andrew D. Medhurst, C. P. L.-H. Chen, Mitchell K.P. Lai
Publikováno v:
British Journal of Pharmacology. 157:130-138
Background and purpose: Histamine H3 receptor antagonists are currently being evaluated for their potential use in a number of central nervous system disorders including Alzheimer's Disease (AD). To date, little is known about the state of H3 recepto
Autor:
Neil Upton, David Virley, Helen Chapman, Martin P. Vidgeon-Hart, Andrew D. Medhurst, Leann P. Quinn, M E Hows, Barry Crook
Publikováno v:
British Journal of Pharmacology. 154:226-233
Background and purpose: The peroxisome proliferator-activated receptor-g (PPARg) agonist pioglitazone has previously been shown to attenuate dopaminergic cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson’